FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts

29Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Fas-Fas ligand (FasL) interaction and apoptosis are important in the mechanism of allograft rejection. However, the interaction between donor and recipient cells, specifically focusing on antigen-presenting cells (APCs), under various conditions is poorly understood in human liver allografts. FasL expression on APCs, its association with apoptosis, and the origin of apoptotic lymphocytes in human liver allografts were assessed by immunohistochemistry and in situ hybridization. We found increased expression of FasL on Kupffer cells (KCs) and endothelium in acute cellular rejection (w = 20) and to lesser extent in chronic rejection (n = 6) and septic cholangitis (n = 5) compared with stable grafts and normal controls. In addition, the graft specificity of infiltrating T cells was confirmed by polymerase chain reaction examination of T-cell receptor-γ loci. T-cell apoptosis occurred at a higher rate in acute cellular rejection than in chronic rejection or septic cholangitis. The number of apoptotic bodies derived from recipient lymphocytes correlated with the severity of rejection and was reversed by treatment. FasL+ KCs phagocytosed CD4+ interferon-γ+ T cells, rather dian CD4+ interleukin-4+ T cells, suggesting a role of KCs in regulating CD4+ T-cell subset differentiation. In conclusion, our data suggest that FasL expression on APCs and phagocytosis of apoptotic T cells by FasL+ KCs are indicators of rejec tion activity in human liver allografts. Copyright © American Society for Investigative Pathology.

Cite

CITATION STYLE

APA

Miyagawa-Hayashino, A., Tsuruyama, T., Egawa, H., Haga, H., Sakashita, H., Okuno, T., … Uemoto, S. (2007). FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. American Journal of Pathology, 171(5), 1499–1508. https://doi.org/10.2353/ajpath.2007.070027

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free